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Abstract
The long-term effect of socioeconomic status (SES) and healthcare resources availability (HCA) on breast cancer stage of
presentation and mortality rates among patients in Michigan is unclear. Using data from the Michigan Department of
Community Health (MDCH) between 1992 and 2009, we calculated annual proportions of late-stage diagnosis and age-
adjusted breast cancer mortality rates by race and zip code in Michigan. SES and HCA were defined at the zip-code level.
Joinpoint regression was used to compare the Average Annual Percent Change (AAPC) in the median zip-code level percent
late stage diagnosis and mortality rate for blacks and whites and for each level of SES and HCA. Between 1992 and 2009, the
proportion of late stage diagnosis increased among white women [AAPC= 1.0 (0.4, 1.6)], but was statistically unchanged
among black women [AAPC=20.5 (21.9, 0.8)]. The breast cancer mortality rate declined among whites [AAPC=21.3%
(21.8,20.8)], but remained statistically unchanged among blacks [AAPC=20.3% (20.3, 1.0)]. In all SES and HCA area types,
disparities in percent late stage between blacks and whites appeared to narrow over time, while the differences in breast
cancer mortality rates between blacks and whites appeared to increase over time.
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Introduction
Overall age-standardized breast cancer mortality rates have
declined significantly over time in the U.S [1–7] and in Michigan
[8]. However, widening disparities in breast cancer mortality
between black and white patients has been consistently reported
across the US and within the state of Michigan [4,9–12].
According to Surveillance Epidemiology and End Results (SEER)
data, breast cancer mortality rates declined from 35 per 100,000
to 29 per 100,000 for black women and from 30 per 100,000 to
21 per 100,000 for white women between 1990 and 2000 [4]. In
Michigan, the breast cancer mortality rate was 23.4 per 100,000
for whites and 33.8 per 100,000 among blacks between 2003 and
2007 [12]. In addition, the National Center for Health Statistics
reported that between 1999 and 2007, black women were more
likely than any other racial group in the US to die of breast cancer
[13].
Possible reasons for the observed racial disparity in mortality
include differential access to breast cancer screening and timely
diagnosis at early stages, as well as adequate treatment [11,14].
Adequate access to screening, diagnosis and treatment were found
to be associated with socio-economic status (SES), both at the
individual and area level [15–18]. For instance, breast cancer
mortality rates in least deprived U.S. counties declined at a higher
rate compared with rates in counties that were most deprived [15].
Individuals with higher SES have better breast cancer outcomes
compared with those with lower SES, even though racial
disparities were still present [19].
In addition, lack of availability of healthcare resources (HCA)
has been associated with poorer outcomes in many aspects of
breast cancer including screening [20], diagnostic follow-up
[21,22], stage of presentation [23,24], treatment [25,26] and
survival [27]. Despite these improvements in our understanding of
the contributors to racial disparities in breast cancer mortality,
more research is needed to understand long term trends in these
factors that influence the racial disparities of breast cancer
outcomes. Recent studies using national SEER data have reported
significant racial and county level socio-economic disparities in
breast cancer screening and mortality trends [15,28,29]. We
sought to assess the presence of racial and socio-economic as well
as HCA disparities on breast cancer stage of presentation and
mortality in Michigan.
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Access to healthcare is a complex, multidimensional concept
that is difficult to distill down to a single measure. It has been
described as encompassing dimensions of availability, accessibility,
affordability and acceptability [30]. Other researchers have further
defined access to healthcare as being a function of enabling factors,
both individual (age, race, income) and neighborhood (number of
physicians, hospitals or mammography centers) [31–33]. For this
study, we chose to focus on the aspect of healthcare availability as
a predictor of breast cancer mortality at the area level.
Although racial disparities in breast cancer mortality have been
reported for a while, we were interested in examining the recent
trends to assess if the disparities appear to be increasing or
decreasing. Furthermore, racial disparities by geography have
been well reported especially since African-Americans and
Hispanics tend to live in different areas than whites. However,
few studies have examined black and white women residing in
similar areas to see if they have similar breast cancer mortality
experiences over time. We were interested comparing women
residing in relatively homogenous areas (zip-code level), further
stratified with regards to SES and HCA.
Several studies have shown that study results can vary
significantly depending on which geographic level neighborhood
variables are measured [34–37]. For this study, the zip code level
was chosen as the ideal level because we believe the census tract
level may be too small geographically to provide a meaningful
measure of healthcare resources available to women. The aim of
this study was to assess the influence of zip-code level HCA and
SES on breast cancer stage at diagnosis and mortality trends for
white and black patients in Michigan between 1992 and 2009.
Methods
Study Population
Annual breast cancer stage of diagnosis and mortality data were
obtained from the Michigan Cancer Surveillance Program
(MCSP) at the Michigan Department of Community Health.
The MCSP is a member of the North American Association of
Central Cancer Registries and is certified for its quality and high
level of data completeness. The data included breast cancer deaths
for patients in the age groups of 20 years and older separately for
blacks and whites in each zip-code in Michigan and for every year
between 1992 and 2009. The stage of diagnosis contained the
proportion of late stage diagnoses separately for blacks and whites
per zip code for each year between 1992 and 2008. Late stage of
diagnosis was defined as regional and distant breast cancer
according to the 2000 SEER summary stage criteria. Annual age-
adjusted mortality rates by race and zip code were calculated using
the 2000 U.S standard population. IRB approval for use of the
data was obtained from the University of Michigan as well as the
Michigan Department of Community health.
Figure 1. Geographical Distribution of Socio-economic Status among Michigan zip-codes.
doi:10.1371/journal.pone.0061879.g001
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Study Variables
Since the analytic dataset consisted of data from 1992 to 2008,
we chose the year 2000 as a mid-point of the interval for which to
define zip-code level SES and HCA. To ensure that our measure
of area-SES was stable, we compared zip-code level SES scores for
1990 and 2000 and found them to be highly correlated
(Correlation Coefficient = 0.94, p,0.05). Therefore, we assumed
that the distribution of zip-code level variables used in our analysis
was similar throughout the study period.
Socio-Economic status. We constructed a measure of zip-
code level SES by using principal components analysis (PCA) using
data obtained from the US Census Bureau [38]. Four variables
that we believe are most closely related to SES based on previous
studies were subject to PCA; a) proportion of adults ages 25 and
older with over 4 years of education, b) proportion of residents
ages 16 and older in the labor force but unemployed, c) proportion
of households in poverty and d) the median household income
[39,40]. The first principal component accounted for 62% of the
variance in the dataset, and was retained for further analysis as
a measure of zip-code level SES. SES was categorized into tertiles
corresponding to low, middle and high SES. The geographic
distribution of SES among Michigan zip-codes is presented in
Figure 1.
Healthcare resources. We sought to define zip code level
HCA as the availability of healthcare personnel and facilities in
Michigan. However, data on healthcare personnel such as the
count of doctors and nurses at the zip-code level for 2000 in
Michigan was not available. Therefore, we defined zip-code level
HCA as the number of hospitals and mammography facilities
available in each Michigan zip-code. A list of names and addresses
of all licensed hospitals in Michigan in 1999 were obtained from
the Division of Licensing and Certification at the Michigan
Bureau of Health Systems. In addition, a list of names and
addresses of all licensed mammography facilities operational in
Michigan in 2000 were obtained from the Michigan State
Radiation Safety Section. For our final analysis, we defined zip-
level HCA as the sum of the number of hospitals and
mammography facilities divided by the zip-code population in
2000, multiplied by 10,000. HCA was categorized into tertiles;
low, middle and high. The geographic distribution of HCA among
Michigan zip codes is presented in Figure 2.
Analytic Methods
Age-adjusted breast cancer mortality rate by race was calculated
for all zip codes in Michigan annually for 1992–2009, and linked
with the dataset containing zip-code level SES and HCA. Annual
median age-adjusted breast cancer mortality rates by race, SES
and HCA were calculated. Median percent late stage diagnosis per
zip code was also calculated by race, SES and HCA. In addition,
Joinpoint regression with a maximum of three joinpoints was used
to compare changes in the median zip-code level mortality rate
and percent late stage diagnosis over time by race, SES and HCA.
Figure 2. Geographical Distribution of Area Healthcare Resources among Michigan zip-codes.
doi:10.1371/journal.pone.0061879.g002
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Joinpoints are used to test for significant changes in the slope or
trend, and also to assess if two regression functions are coincident
or parallel (Joinpoint, Version 3.5.1). Trends in median age-
adjusted mortality and percent late stage by race, SES and HCA
are defined as increasing or decreasing when the Annual Percent
Change is statistically significant (p,0.05), and stable if otherwise.
Significant trends throughout the entire years of analysis are also
assessed by the Average Annual Percent Change (AAPC).
Furthermore Poisson regression was used to model the temporal
trend in annual median mortality rate and percent late stage by
race adjusting for area SES and HCA.
Results
Percent Late Stage Diagnosis
Between 1992 and 2008, 27% of black patients and 21% of
white patients were diagnosed at a late stage (Table 1). Median
percent late stage diagnosis declined as zip-code SES increased for
both black and white patients. The median percent late stage
diagnosis for black patients was 33%, 17% and 11% for low,
middle and high SES zip-codes respectively. Among white patients
the median proportion of late stage diagnosis was 23%, 21%, 20%
for low, middle and high SES zip-codes respectively (Table 1).
Median percent late stage diagnosis for black patients was 29%,
26% and 27% for low, middle and high HCA zip-codes
respectively. Among white patients, the median percent late stage
of diagnosis was 20%, 25% and 23% for low, middle and high
HCA zip-codes respectively (Table 1).
Black patients were consistently diagnosed at a late stage more
frequently than white patients over time (Figure 3–1). However,
there was a statistically significant increase of 4.5% (CI: 0.4, 8.7) in
late stage diagnosis among white patients between 2002 and 2006
(Table 2). There were also apparent differences in late stage of
diagnosis between SES groups (Figure 3–2). Late stage diagnosis
among the low SES group remained stable over the study period,
but increased in the middle and high SES groups (Table 2). Clear
gradients also existed between HCA groups (Figure 3–3). The high
HCA group experienced a statistically significant increase which
narrowed the gap between middle and high access groups by 2008
(Table 2). The low HCA group experienced several statistically
significant trends, although remained lower than other groups.
Significant disparities in late stage diagnosis were also observed
between blacks and whites when examined within strata of zip-
code level SES and HCA (Figure 4). Blacks were more likely to be
diagnosed at a late stage in each of the area types. In most area
types except low SES/high HCA and mid SES/high HCA, the
percentage of late stage diagnosis among blacks declined over
time. In contrast, among white patients the percentage of late stage
diagnosis increased over time in most area types, excluding mid
SES/low HCA, high SES/mid HCA and high SES/low HCA. In
all area types, differences in percent late stage between blacks and
whites appear to have narrowed over time.
Age-Adjusted Mortality Rates
Between 1992 and 2009, 3,684 black patients and 20,241 white
patients died of breast cancer in Michigan (Table 1). Age-adjusted
breast cancer mortality rate during this period was 32 per 100,000
among black patients and 29 per 100,000 among white patients.
Among black patients, median age-adjusted breast cancer
mortality rate increased as zip-code level SES increased. The
median age-adjusted mortality rate was 28 per 100,000, 41 per
100,000 and 72 per 100,000 for low, middle and high SES zip-
codes respectively. Among white patients, the reverse trend was
observed; the median age-adjusted mortality rate was 38 per
100,000, 32 per 100,000 and 25 per 100,000 for low, middle and
high SES zip-codes respectively. As zip-code level HCA increased,
median age-adjusted mortality rate increased for black patients;
32 per 100,000, 32 per 100,000 and 34 per 100,000 for low,
middle and high HCA zip-codes respectively. Among white
patients, the median age-adjusted mortality rate was 34 per
100,000, 22 per 100,000 and 26 per 100,000 for low, middle and
high HCA zip-codes respectively.
Between 1992 and 2009, the age-adjusted breast cancer
mortality rate appeared to have declined among whites, but
remained statistically unchanged among blacks, resulting in higher
rates among blacks patients compared with whites (Figure 3–4).
There were no joinpoints in median mortality rates for blacks,
however whites observed a statistically significant change of
21.3% (CI: 21.8, 20.8) during the study period (Table 2). There
were initial large differences in rates between SES levels in 1992
with the highest rates among low and middle SES groups but these
appeared to have narrowed significantly by 2006 (Figure 3–5).
This trend is reflected in the statistically significant joinpoints in
median mortality rates for low and middle SES groups (Table 2).
There are also clear gradients between the three HCA groups; low
HCA groups had the highest mortality rate, followed by high
HCA and middle HCA groups (Figure 3–6). All three HCA
groups had statistically significant joinpoints that suggested
declining rates over time. Each of the HCA groups were
statistically different from each other (i.e. not coincident), but
were parallel to each other.
In all area types, blacks had higher mortality rates compared
with whites, and the disparity between the two racial groups
appeared to have increased over time (Figure 5). Among black
patients, the age-adjusted mortality rate showed marked increases
in all area types except mid SES/mid HCA. The largest increase
appeared to be in high SES areas, regardless of HCA. Among
white patients, annual age-adjusted mortality rates declined in all
area types except high SES/high HCA, high SES/mid HCA and
high SES/low HCA. The largest increase in mortality rates among
black women also was observed in high SES areas, regardless of
HCA. In all area types, differences in age-adjusted breast cancer
Table 1. Distribution of Breast Cancer Mortality and Percent
Late Stage by Zip-Code Characteristics.
Frequency % (n)
Median
Mortality Ratea % Late Stageb
Black White Black White Black White
Total 13.3 (3,684) 86.7 (20,241) 32.07 28.80 27.27 21.05
SES
Low 76.1 (2,804) 17.6 (3,572) 27.99 38.35 33.33 23.08
Middle 11.5 (422) 29.9 (6,055) 40.63 31.74 16.67 20.83
High 11.7 (431) 51.3 (10,390) 72.15 25.47 10.79 20.00
HCA
Low 57.1 (2102) 48.3 (9776) 31.63 34.19 28.57 20.00
Middle 32.6 (1201) 34.9 (7079) 32.23 21.79 26.12 25.00
High 9.6 (355) 15.7 (3171) 33.95 25.89 26.97 23.08
aMedian of zip-code and year specific mortality rates by race, 1992–2009.
bMedian of zip-code and year specific proportion of late stage by race, 1992–
2008.
doi:10.1371/journal.pone.0061879.t001
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mortality rates between blacks and whites appear to have
increased over time.
Discussion
The purpose of this study was to assess trends in late stage
diagnosis and breast cancer mortality rate among black and white
women in Michigan between 1992 and 2009, accounting for area
SES and HCA. Our findings suggest that in the past 18 years,
black and white breast cancer patients in Michigan have had
different experiences with the disease based, in part, on their area
of residence. In the period between 1992 and 2008, when both
racial groups are initially examined without accounting for area
type, the proportion of late stage presentation increased annually
by 1.0% among white patients, but remained statistically un-
changed among black patients. In the same period, the breast
cancer mortality rate declined annually by 21.3% among white
patients but remained statistically unchanged among black
patients.
Further examination of the trends based only on area SES
characteristics suggests that the proportion of late stage pre-
sentation narrowed between SES groups by 2008. This narrowing
trend was due to the increase in the proportion of late stage
presentation among the middle and high SES groups, compared
with the statistically unchanged trend among the low SES groups.
Similarly, a narrowing of the mortality rate trend occurred
between 1992 and 2009; although mortality rates in the high SES
group remained statistically unchanged, the low and middle SES
groups experienced significant declines in mortality rates irrespec-
tive of race. This trend resulted in limited disparity in breast
cancer mortality rates between low, middle and high SES groups
by 2009, irrespective of race. When outcomes were further
examined based only on area HCA, surprisingly, the proportion of
late stage presentation appeared lower among the low HCA group
and highest among the middle HCA group. However, by 2008,
the low and high HCA groups had experienced significant
increases, while the middle HCA remained statistically un-
changed. This trend resulted in similarly higher rates for high
and middle HCA groups compared with the low HCA groups at
the end of the period. Mortality rates declined for all HCA groups;
however, disparities remained between the groups at the end of the
study period irrespective of race.
Additionally, examining late stage diagnosis and mortality rate
trends between black and white patients from similar area types
suggests that large disparities still remained at the end of the study
period. Black patients were consistently diagnosed at a late stage
more frequently than whites, although they have experienced
a significant reduction in the proportion of late stage diagnosis
over time. White patients, on the other hand, experienced
Table 2. Trends{ in Percent Late Stage (1992–2008) and Median Mortality Rate (1992–2009) by Race, SES and HCA.




Years APC (95% CI) Years APC (95% CI) Years APC (95% CI)
Percent Late Stage
Race
Black 1992–1995 27.9 (217.9,3.4) 1995–2002 2.0 (21.9,6.1) 2002–2008 22.4 (26.1,1.5) 20.5 (21.9, 0.8)
White 1992–2001 20.4 (21.6,0.7) 2001–2006 4.5 (0.4–8.7)* 2006–2008 25.3 (216.5,7.4) 1.0 (0.4,1.6)*
SES
Low 1992–2002 20.0 (22.1,2.1) 2002–2006 5.2 (28.0,20.2) 2006–2008 210.1 (231.2,17.4) 0.7 (20.2,1.7)
Middle 1992–1994 17.2 (211.6,55.4) 1994–1997 27.0 (229.9,23.2) 1997–2008 2.5 (0.5,4.4)* 1.4 (0.2,2.6)*
High 1992–1997 22.8 (26.7,1.2) 1997–2008 1.6 (0.4,2.9)* 1.6 (0.4,2.9)*
HCA
Low 1992–1994 18.9 (0.9,40.0)* 1994–1997 27.7 (221.6,8.7)* 1997–2008 1.9 (0.8,3.0)* 1.9 (0.8,3.0)*
Middle 1992–1999 21.6 (23.2,0.2) 1999–2002 2.7 (29.8,16.8) 2002–2008 0.2 (22.0,2.4) 0.1 (20.5,0.7)
High 1992–1994 210.3 (237.5,28.7) 1994–2008 2.0 (0.3,3.7)* 2.0 (0.3,3.7)*
Mortality Rate
Race
Black 1992–2000 20.2 (22.6,2.3) 2000–2007 1.5 (22.3,5.5) 2007–2009 26.0 (225.1,18.0) 20.3 (20.3,1.0)
White 1992–1995 1.4 (27.4,11.1) 1995–1998 22.8 (218.9–16.7) 1998–2009 21.2 (22.4, 20.0)* 21.3 (21.8, 20.8)*
SES
Low 1992–2002 22.6 (24.6, 20.6)* 2002–2006 20.7 (212.9,13.1) 2006–2009 22.9 (214.8,10.6) 22.1 (22.9, 21.3)*
Middle 1992–2004 21.4 (22.5, 20.3)* 2004–2007 1.5 (215.9,22.5) 2007–2009 25.7 (221.9,13.8) 21.2 (21.7, 20.7)*
High 1992–1994 3.5 (28.0,16.3) 1994–2002 20.0 (21.6,1.6) 2002–2009 21.1 (22.7,0.4) 20.3 (20.8,0.3)
HCA
Low 1992–1995 0.5 (27.7,9.4) 1995–2009 21.1 (21.8, 20.3)* 20.9 (21.4, 20.4)*
Middle 1992–2001 22.0 (23.9, 20.1)* 2001–2007 20.4 (25.0,4.5) 2007–2009 26.8 (224.7,15.4) 21.6 (22.2, 21.0)*
High 1992–2003 21.9 (23.6, 20.2)* 2003–2007 3.2 (29.2,17.1) 2007–2009 27.3 (228.1,19.6) 21.0 (21.7, 20.2)*
*P,0.05; APC Annual Percent Change; CI Confidence Interval; {Trend years may include different time periods based on Joinpoint regression modeling.
doi:10.1371/journal.pone.0061879.t002
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significant increases in the proportion of late stage diagnosis in all
area types. The reverse scenario is observed in age-adjusted
mortality rates. Black patients had higher mortality rates than
white patients in all area types, and they have observed a significant
increase in mortality rates over time. The largest annual increase
appeared to have been among black patents in the high SES/high
HCA group; this group had the smallest amount of disparity
between black and white patients at the beginning of the study
period. White patients in the high SES/high HCA group also
experienced a large increase in mortality rate during the study
period.
Overall across all the study years, the highest proportion of late
stage diagnoses was observed among black patients, patients
residing in low SES zip-codes and patients residing in middle
HCA zip-codes. The groups that had the highest breast cancer
mortality rates were black patients, patients residing in low SES
zip-codes and patients residing in low HCA zip-codes. These
findings are similar to others that have found consistent disparities
in cancer outcomes by race, socio-economic status and HCA [28].
In addition, other studies have reported the correlation between
late stage at diagnosis and high mortality rates, especially among
blacks [10,41]. This correlation has been attributed to the lower
likelihood of receiving appropriate treatment, and a higher
likelihood of co-morbid conditions such as diabetes and hyper-
tension [42–44]. Other studies suggest that aggressive, triple-
negative breast cancer sub-types may be responsible for the higher
mortality rates observed among blacks [45]. These cases account
for less than 25% of all invasive breast cancer cases, with higher
rates observed among blacks compared with whites [46].
Therefore, research efforts should be focused on understanding
factors such as SES and HCA that affect the vast majority of breast
cancer patients of all races, but may also be related to the
development of aggressive breast cancer sub-types [47].
The trend of higher mortality rates in higher SES areas has
been observed previously at the county level [15]. Possible
explanations for the high percent late stage diagnosis and age-
adjusted mortality rate among black patients even in high SES and
HCA zip-codes could be attributed to other dimensions of access
to healthcare not captured by availability of healthcare resources.
Cultural or language barriers as well as historical mistrust of the
medical system could potentially limit the ability of black women
to benefit from available healthcare resources. These factors have
been consistently associated with reduced contact with healthcare
facilities among minority populations in the US [48,49].
Furthermore, residing in a high SES zip-code may not
necessarily mean higher SES individually. Lack of reliable
transportation, time off from work or health insurance may be
major factors that could preclude routine use of healthcare
facilities. Furthermore, research studies have suggested that
retaining social and family networks are a major reason why
black women reside in low SES areas [50]. Consequently, residing
in a high SES area may result in the loss of established social
networks that have also been shown to be important to improved
psychosocial wellbeing and health outcomes [49,51,52]. In
addition, other studies have shown that large disparities exist in
disease outcomes including mortality between blacks and whites,
and these disparities are sometimes largest in high SES neighbor-
hoods [53,54]. This may be due to reasons such as psychosocial
stress, perceived racism, or social isolation.
Figure 3. Median Predicted Zip-Code Percent Late Stage Diagnosis (1992–2008) and Age-Adjusted Mortality Rate (1992–2009) by
Race, SES and HCA.
doi:10.1371/journal.pone.0061879.g003
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Another possible reason for the high mortality rates observed in
high SES and HCA zip-codes is out-migration of low risk
individuals from these areas, however this migration would have
to be differential based on risk. That is, there would have to be
a selection factor that made low risk individuals more likely to
move out compared to high risk individuals. It is difficult to test
this empirically since we do not have access to data on breast
cancer risk factors for this study. In addition, if such high SES zip-
codes also had better healthcare facilities, it is conceivable that in-
migration of high risk individuals (or those already diagnosed
breast cancer cases) would also increase observed mortality rates.
Among white patients in Michigan, the observed increase in the
proportion of late stage diagnosis is surprising, and further studies
are warranted to replicate this finding and to offer potential
reasons. This may be a finding unique to Michigan due to the
severe economic downturn experienced in the state. This could
have resulted in loss of employment, loss of insurance coverage for
individuals and families, potentially resulting in less access to
healthcare resources and lower cancer screening rates. We were
unable to test this empirically in this study, and further research in
this area is warranted. In addition, we cannot discount the
possibility of an increase in aggressive sub-types of breast cancer
among white women which progresses very rapidly and may not
always be detected by annual mammography screening. However,
more research is also needed in this area.
Among white women residing in high SES neighborhoods,
mortality rates appeared to increase. It is reasonable to expect that
inconsistencies in breast cancer medication use (which can be quite
expensive) may lead to higher mortality in this group. We believe
that in high SES areas, it is possible for a family to lose a source of
income but still make enough to be disqualified from programs
focused on cancer screening and treatment for low income women
e.g. the Michigan Breast and Cervical Cancer Control program.
In addition, women who have been covered by health insurance
for a long period of time may be unaware that such services even
existed. This same reasoning may apply to the increase in
proportion of late stage diagnosis observed in middle and high
SES areas; lack of familiarity with programs that have traditionally
been designed to assist low income women may have put women
residing in middle and high SES areas at a disadvantage compared
with women residing in low SES areas. These are potential areas
for future research studies.
A major strength of this study is the measure of area
characteristics at the zip-code level, a smaller geographic area
than the county which may provide a more homogenous
population with respect to SES and HCA. Most research studies
use county level characteristics in assessing SES disparities in
breast cancer [15,28,29,32,55–57], and none has assessed zip-code
level characteristics in relation to breast cancer in Michigan. In
addition, the availability of data on area SES and HCA improved
our ability to parse out differences in late stage and mortality
trends between black and white women residing in similar areas.
There are inconsistencies in the literature about at level at which
to measure area level variables, however we believe that it is
important to choose a geographic level that makes sense for the
disease entity being studied. Since breast cancer is a relatively rare
disease, and healthcare resources are not likely concentrated at
very small levels such as the census tract, we believe that the use of
zip codes as our geographic unit is ideal for our research aim.
Figure 4. Median Predicted Zip-Code Percent Late Stage Diagnosis (1992–2008) by Race and Neighborhood Type.
doi:10.1371/journal.pone.0061879.g004
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There are some limitations to this study. First, HCA was defined
based only on the availability of healthcare facilities at the zip-code
level. The availability of healthcare personnel could have
improved this measure, but lack of data precluded its inclusion
in this analysis. However, facilities and personnel are likely highly
correlated at the area level i.e. the more facilities available, the
more personnel will be present. In addition, zip-code level
measures of SES and HCA were used in this study as indirect
measures; we did not account for the potential porosity of
geographic boundaries in which residents of low HCA zip codes
may have access to and chose to travel to high HCA zip-codes for
healthcare. Furthermore, zip codes that did not exist during the
2000 census were dropped from the analysis, potentially in-
troducing some bias if these zip codes were significantly different
from the rest of the state in terms of our outcome of interest.
In summary, future studies in the US should focus on better
understanding the factors contributing to the rise and fall of
proportion of late stage at diagnosis and mortality rate trend over
time through detailed analysis of trends in risk factors known to be
associated with these outcomes. In addition, in-depth clinical
studies are needed to explore the possibility of rising aggressive
sub-types of breast cancer among white women. These aggressive
cancers may be partly responsible for rising late stage diagnosis
among white women, and understanding this sub-group may help
researchers in developing guidelines for more frequent screening
in this population. This study and future research will be very
helpful in better understanding population sub-groups that are
disproportionately experiencing adverse outcomes despite im-
provements in screening and treatment regimens. It will be very
helpful to examine trends in other regions of the US that may have
experienced significant economic downturn to assess the impact of
loss of employment and insurance on breast cancer stage at
presentation and mortality. Globally, as breast cancer rates are
projected to increase, it will be important to conduct studies like
these to identify vulnerable sub-groups that may benefit from
concentrated resources aimed at increasing access to timely
screening and adequate treatment.
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